A STUDY ON PATIENTS' AWARENESS, RECOGNITION MANAGEMENT AND PREVALENCE OF HYPOGLYCEMIC EPISODES IN TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL
Abstract
Objective: To assess patients' awareness on management of hypoglycemic episodes and analyzing the prevalence of hypoglycemic episodes in
patients with Type 2 diabetes mellitus.
Methods: A prospective-observational comparative study was carried out for a period of 6 months in the outpatient unit of endocrinology and general
medicine department. Patients who had hypoglycemic episodes were classified into mild, moderate and severe hypoglycemia with respective to
age, anti-diabetic therapy and co-morbidities. Prevalence of hypoglycemia was calculated using prevalence formula; hypoglycemic episodes for antidiabetic
therapy were compared using ANOVA and independent t-test.
Results: Of 200 patients, (43%) were male and (57%) were female patients. Patients with systemic hypertension (30%) were more predominant than
other co-morbid conditions. According to anti-diabetic therapy (49.5%) patients were on oral hypoglycemic agents (OHA's), (16.5%) on insulin and
(34.5%) on both insulin and OHA's. The calculated value of t (2.831) was greater than table value (2.45) and mean of OHA (24.75) was greater than
the mean of insulin (8.25). Prevalence of hypoglycemia was (51%).
Conclusion: The results from this study showed that more number of patients taking OHAs was found to experience hypoglycemia and patients with
SHT as co-morbid condition were found to experience hypoglycemia than other co-morbid conditions. Prevalence of hypoglycemia was found to be
more in females and elderly population.
Keywords: Hypoglycemic episodes, Prevalence, Insulin, Oral hypoglycemic agents, Co-morbid condition.
Downloads
References
Gubitosi-Klug RA. Diabetes control and complications trial, 1983-1993. Diabetes Care 2014;37:2-4.
American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care 2008;31 Suppl 1:S12-54.
Wright RJ. Hypoglycaemia case study - impaired awareness of hypoglycaemia, clinical case studies. Diabet Hypoglycaemia 2008;1(2):13-4.
Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med - Impaired awareness and cognition of hypoglycaemia; research round up. Diabet Hypoglycaemia 2008;1(1):10-1.
Martin Gillmor of the Diabetic Hypoglycaemia Editorial team. Hypoglycaemia risk with oral antidiabetic drugs, diabetes treatment review. Diabet Hypoglycaemia 2009;1(3):17-8.
International Diabetes Federation. Global Guidelines for Type 2 Diabetes 2005. Available from: http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf. (Guidelines for Management of Hypoglycaemia in older adults). [Last accessed on 2013].
Jermendy G, Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, et al. Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary. Health Qual Life Outcomes 2008;6:88.
Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in Type 2 diabetes. Diabet Med 2008;25(3):245-54.
Hope SV, Strain WD. Hypoglycemia in the elderly. Diabet Hypoglycemia 2013;6(1):3-10.
Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, Tschöpe D. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycaemia. Diabet Hypoglycaemia 2010;3(2):17-9.
Greco D, Angileri G. Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older. Diabetes Nutr Metab 2004;17(1):23-6.
Foster J, Baillie PA, Strain WD. Hypoglycemia precipitating prolonged QT interval and myocardial ischemia in a patient with coronary heart disease and renal failure. Diabet Hypoglycemia 2012;4(3):9-11.
Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Am Diabetes Assoc 2009;2:124-7.
Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007;357(17):1716-30.
Robinson E. Hypoglycaemia case study end stage renal disease and hypoglycaemia. Diabet Hypoglycaemia 2009;1(3):13-4.
Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE. Renal glucose production and utilization: New aspects in humans. Diabetologia 1997;40(7):749-57.
Heller S, McCrimmon R. The accord and advance trials-could hypoglycaemia have contributed to differences seen in cardiovascular mortalities. Diabet Hypoglycaemia 2008;1(2):1.
Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT. Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients. Diabetes Care 2001;24(5):886-90.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared to conventional therapy and risk of complications in type 2 diabetes. Lancet 1998;352:837-53.
Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281(21):2005-12.
Berger W. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides. Horm Metab Res Suppl 1985;15:111-5.
Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis. Diabetes Care 2008;31(11):2086-91.
Campbell IW. Sulfonylureas and hypoglycaemia. Diabet Hypoglycaemia 2009;1(2):3-10.
Campbell I. Hypoglycaemia case study - Rebound hypoglycaemia associated with glibenclamide. Diabet Hypoglycaemia 2009;2(1):14-5.
Signorovitch JE, Macaulay D, Diener M, Yan Y, Wu EQ, Gruenberger JB, et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab 2013;15(4):335-41.
Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El‑Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161(13):1653-9.
Frier B. Welcome to diabetic hypoglycemia – An essential new source for hypoglycemia awareness. Diabetic Hypoglycemia 2008;1(1):2-7.
Frier BM. Hypoglycaemia in type 2 diabates. Diabet Hypoglycaemia 2008;1(1):2-7.
Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns 2007;68(1):10-5.
Stahl M, Berger W. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Diabet Med 1999;16(7):586‑90.
Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Severe sulfonylurea-induced hypoglycemia: A problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf 2010;9(5):675-81.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.